Before you decide you have "done enough" for MRCPCH Theory and Science (TAS), you need evidence, not a completion bar. This is a checklist, not a study timetable: it sets out the minimum you should be able to show — across coverage, format, interpretation, recency and performance — before you stop doing new questions. Work through it honestly, and if any line cannot be ticked with data rather than a feeling, that line is your next block. TAS is the science-and-mechanisms written paper, and the gaps it punishes are the ones self-selected practice tends to hide.
The minimum evidence, stated as a checklist
You can say you have covered TAS when, and only when, you can show: unseen, timed, mixed-block accuracy at or above your floor in every RCPCH content area; deliberate practice — not just incidental exposure — in the mechanistic and interpretive skills the paper tests; a source date and jurisdiction recorded for every guidance-sensitive topic; a low high-confidence error rate and retention that holds at a spaced interval; and calibration against the RCPCH specimen paper. Completion of any single bank is not on that list, and neither is a headline percentage.
Current exam snapshot
TAS is 100 single best answer questions in two hours, one mark each, no negative marking, computer-based at an exam centre or online — about seventy seconds per item, and it may be sat the same day as Foundation of Practice. It shares the RCPCH content map with the other theory papers but emphasises the scientific basis of practice: pharmacology and mechanisms of drug action, genetics and dysmorphology, metabolic medicine, physiology, immunology, haematology, and the science of practice, which includes evidence and statistics. The authoritative sources are the RCPCH theory syllabus and the official specimen paper. Crucially, RCPCH does not publish a fixed numerical weighting of questions per domain, so no bank can promise blueprint completeness and no "weighting" column below should be treated as an official figure — it is your own estimate of emphasis, to be sampled broadly.
The blueprint coverage table
Build this table and fill it from your own data. The "emphasis" column is your judgement of how heavily TAS samples an area, since RCPCH publishes no fixed weighting; the point of the table is to expose cells where attempts are low, accuracy is weak, review is stale, or confidence is bluster.
| RCPCH content area (TAS emphasis) | Emphasis (your estimate) | Questions attempted | First-attempt accuracy (unseen) | Last reviewed | Confidence |
|---|---|---|---|---|---|
| Pharmacology and drug mechanisms | High | — | — | — | — |
| Genetics and dysmorphology | High | — | — | — | — |
| Metabolism and metabolic medicine | High | — | — | — | — |
| Immunology and allergy | Medium | — | — | — | — |
| Nephro-urology (renal physiology, fluids) | Medium | — | — | — | — |
| Haematology and oncology | Medium | — | — | — | — |
| Endocrinology and growth | Medium | — | — | — | — |
| Neonatology (transitional physiology) | Medium | — | — | — | — |
| Science of practice (evidence and statistics) | Medium | — | — | — | — |
| Infection, immunology and microbiology | Medium | — | — | — | — |
Ten domain-level blind spots that stay hidden
These are the areas self-selected practice most often leaves thin in TAS, because they are effortful, easy to avoid, or feel "done." Have an exam-experienced paediatric clinician review your coverage of them before you conclude you are ready — a second clinician's eye catches gaps a candidate rationalises away.
- Inborn errors and metabolic medicine — mechanisms rather than pattern recognition; easy to skim.
- Genetics and dysmorphology — inheritance patterns, imprinting and mechanism, not just syndrome spotting.
- Pharmacology and drug mechanisms — how antibiotics and anti-epileptics actually work, verified against the SmPC/eMC.
- Immunology — complement, immunodeficiency and hypersensitivity mechanisms.
- Statistics and evidence (science of practice) — study design, bias, and interpreting a trial, routinely under-practised.
- Neonatal transitional physiology — circulation, thermoregulation and adaptation.
- Renal physiology and acid–base — fluid, electrolyte and tubular handling.
- Haematology mechanisms — haemoglobinopathies and coagulation pathways.
- Endocrine axes — feedback loops and hormonal mechanisms rather than end-disease facts.
- Ophthalmology and less-loved systems — small in volume, reliably neglected, and examinable.
Format checklist: mechanistic reasoning
TAS rewards mechanism. Verify you have practised deliberately, not incidentally, in: mechanistic reasoning (can you explain why, not just what); genetics and inheritance; physiology across systems; and pharmacology at the level of mechanism and interaction. For each, the test is whether you can produce the reasoning cold on an unseen item, and whether you have verified the science against a primary source rather than a bank note.
Interpretation checklist
Verify deliberate practice, options hidden, across the interpretive formats TAS uses: images (rashes, films, ophthalmology and ENT); data trends including blood gases and laboratory series; growth data where relevant; calculations and unit conversions; and the statistics and evidence items within the science of practice. Interpretation is a produce-the-finding skill, and a bank's four options quietly train it away — so the check is whether you can name the finding before the options appear, across every format.
Recency checklist
TAS science is more stable than acute-management guidance, but not immune to change, and any management-adjacent item is guidance-sensitive. For each guidance-sensitive topic, record the date and jurisdiction of your source, and confirm it against UK references — NICE, CKS, RCPCH guidance and the SmPC/eMC for medicines. Do not carry a remembered figure from an old edition, and do not treat a children's-formulary abbreviation as the primary source when the summary of product characteristics is. A dated, jurisdiction-stamped source is the tickable evidence here.
Performance checklist
Coverage without performance is a false comfort. Verify: unseen, timed, mixed-block accuracy at or above your floor in every area; safe pace at around seventy seconds per item; a low high-confidence error rate, since confident wrong answers are the dangerous ones; retention at a spaced interval rather than on the day of learning; and calibration against the RCPCH specimen. If any of these is untested, it is not covered — it is assumed.
Stop/continue decision tree
Read your table and route accordingly. If a domain sits below floor, continue new questions there — the gap is knowledge. If domains are at floor but retention is slipping, stop adding new items and consolidate — re-test coded misses cold and space them. If coverage and retention are sound but pace or exam feel is off, simulate — full unseen timed papers and the RCPCH specimen. If a specific mechanism will not stick despite focused work, seek teaching — a clinician can unpick a misconception faster than another block will. And if every line is ticked with data, rest — protect the performance you have rather than eroding it with fatigue. Each branch turns on a measured gap, never on novelty or the sunk cost of a subscription.
One-page checklist and a worked example
Copy this into your notes as a single page and tick each line only with data:
- Coverage: unseen accuracy at or above floor in every RCPCH content area.
- Format: deliberate practice in mechanistic reasoning, genetics, physiology and pharmacology.
- Interpretation: finding named before options across images, data, calculations and statistics.
- Recency: date and jurisdiction recorded for every guidance-sensitive source.
- Performance: safe pace, low high-confidence error rate, retention at interval, specimen calibration.
- Review: an exam-experienced paediatric clinician has checked the ten blind-spot domains.
A worked example, with invented figures for illustration only. A trainee three weeks out fills the table and finds pharmacology at 78% unseen accuracy (above floor, last reviewed this week — sound), but metabolic medicine at 54% with attempts low and last review a month ago, and the statistics items within science of practice at 61% with high confidence on the wrong answers. The decision tree routes clearly: metabolic medicine is below floor, so it earns new, targeted questions and a primary-source pass; the statistics items are a high-confidence error problem, so they earn coded review and transfer practice rather than volume; pharmacology needs only spaced maintenance. The candidate does not stop doing new questions — but the table has told them exactly which new questions, and which domains to leave alone.
Filled in, that candidate's table looks like this — all figures invented for illustration, not real data:
| RCPCH content area | Emphasis | Attempted | Unseen accuracy | Last reviewed | Confidence |
|---|---|---|---|---|---|
| Pharmacology and drug mechanisms | High | 180 | 78% | This week | High |
| Genetics and dysmorphology | High | 90 | 71% | 8 days | Medium |
| Metabolism and metabolic medicine | High | 40 | 54% | ~1 month | Low |
| Immunology and allergy | Medium | 60 | 66% | 2 weeks | Medium |
| Science of practice (statistics) | Medium | 55 | 61% (high-confidence errors) | 10 days | High |
| Neonatal physiology | Medium | 35 | 59% | 3 weeks | Low |
Read across the rows and the plan writes itself: metabolic medicine and neonatal physiology are below floor with stale review dates, so they earn new, targeted questions and a primary-source pass against RCPCH guidance and the SmPC/eMC; the statistics row pairs a middling score with high confidence — the signature of a candidate who is sure and wrong — so it earns coded review and transfer practice rather than fresh volume; genetics is near floor and holding, needing only light maintenance; pharmacology needs only spaced review. Notice what the table refuses to let the candidate do: coast on a healthy-looking progress bar while two high-emphasis domains sit unsafe. Completion would have whispered "ready"; the coverage table says plainly, "three named jobs remain, and here is the order."
The same table also protects against over-working. Pharmacology at 78% with a recent review does not need another hundred questions the week before the exam; adding them steals time from the metabolic-medicine gap that actually threatens the mark. This is the quiet value of a coverage table over a running percentage — it shows you not only where to push but where to stop, so effort follows the measured gap rather than the most comfortable domain.
Three mistakes this checklist is designed to stop
The first is reading completion as coverage. A bank shown as fully worked tells you that you have seen its items, not that you can produce their reasoning on unseen ones; coverage lives in the unseen-accuracy column, never in the progress bar, and treating the two as the same is the most common way a well-prepared candidate is caught out on the day.
The second is trusting a high-confidence percentage. Confident wrong answers are the ones that cost marks, and an overall percentage buries them inside its average; a candidate scoring seventy per cent made up of calm, careless errors is in more danger than the number suggests. That is why the checklist isolates the high-confidence error rate as its own line — it is the single most diagnostic figure you can track, and the one a headline percentage is built to hide.
The third is letting recency rot silently. TAS science feels stable, so candidates stop dating their sources; then a management-adjacent item turns on a threshold that has shifted, and a remembered figure from an old edition quietly costs a mark. Recording the date and jurisdiction of every guidance-sensitive source, and checking it against NICE, CKS, RCPCH guidance and the SmPC/eMC, is dull work and it is the cheapest mark you will ever protect.
Bottom line
Coverage for TAS is a claim you should be able to defend with data, not a feeling that you have "done the bank". When your coverage table shows unseen, timed accuracy at or above floor in every area, a low high-confidence error rate, retention that holds at interval, and calibration against the RCPCH specimen, you have earned the right to stop doing new questions. Until then, the empty and weak cells — not the completion percentage — are your syllabus, and they will tell you both what to study next and, just as usefully, what to leave alone.
FAQ
How do I know whether I have covered the full MRCPCH Theory and Science blueprint? You know it from a filled coverage table, not from a completion bar, because RCPCH publishes the content areas but not a fixed numerical weighting per paper. Map every content area against attempts, unseen first-attempt accuracy, last review date and confidence, and treat an area as covered only when unseen timed performance sits at or above your floor there and calibrates against the official specimen. Empty or weak cells are your remaining blueprint, whatever the headline percentage says.
Can one question bank be enough for MRCPCH Theory and Science? One strong paediatric bank can be your primary learning tool, but it cannot also be your measurement, because once you have drilled it your score reflects familiarity with its items rather than transfer to new ones. Keep a second, unseen bank as the measurement layer, and use the finite official specimen as your calibration standard. Sufficiency is a property of your unseen performance, not of any single product's completion.
What should I measure instead of my overall Q-bank percentage for MRCPCH Theory and Science? Measure first-attempt accuracy on unseen, timed, mixed blocks; per-domain floors so no science area is quietly failing; pace against the roughly seventy-seconds-per-item the paper allows; your high-confidence error rate, which is where unsafe answers hide; retention at a spaced interval; and calibration against the RCPCH specimen. An overall percentage on a bank you have worked measures comfort, which is exactly why it is not your exam score.
When should I stop doing new MRCPCH Theory and Science questions? Stop when your coverage table is ticked with data: unseen timed accuracy at or above floor across every area, safe pace, rare high-confidence errors, retention holding at interval, and performance calibrated to the specimen. At that point new volume is low-yield and the higher-value work is consolidation, simulation and rest. If any line is untested, that line — not the completion bar — is your reason to keep going.
Which MRCPCH Theory and Science resource should I use for my weakest component? Match the resource to the failure type. A science knowledge gap points to a dedicated paediatric bank and to primary sources — RCPCH guidance, NICE, CKS and the SmPC/eMC for mechanisms and dosing. An interpretation gap needs targeted image, data and statistics sets worked with the options hidden and a clinician's review. A high-confidence error pattern needs coded review and transfer practice rather than more volume. And a mechanism that will not stick despite focused work needs teaching from a clinician, which resolves a misconception faster than another block.
Editorial notes and references
Written by Dr Kolawole Tytler, NHS GP and founder of iatroX. Last checked 20 July 2026. Exam-format facts are from the RCPCH theory examination pages; the worked-example figures are invented for illustration and are not real candidate data; any vendor figures cited in this series are vendor-reported on the date shown and should be re-checked on the product page. Disclosure: iatroX operates a UK question bank and competes with the paediatric banks referenced here; its role in this checklist is confined to unseen measurement and transfer practice, and it does not publish a dedicated MRCPCH bank. Corrections are welcome via the feedback route on iatrox.com.
References: RCPCH — Theory exams, structure and syllabi (rcpch.ac.uk/education-careers/examinations/theory/structure-syllabi); RCPCH — Theory exam sample papers (rcpch.ac.uk/resources/theory-exam-sample-papers). Internal: the blueprint-coverage matrix; the two-Q-bank rule; and "Your Q-Bank Percentage Is Not Your Exam Score" on iatrox.com; comparison hub at iatrox.com/compare.